Form 4 for ABBV AbbVie
Accepted 2024-07-19 00:00:00 ET · period of report 2024-07-17 · accession 0000897069-24-001526 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2024-07-19 | 2024-07-17 | ABBV | GONZALEZ RICHARD A | EXECUTIVE COB OF BOARD, Dir | M - OptEx | $77.49 | +282.8K | 600.1K | +89% | +$21.92M |
| DT | 2024-07-19 | 2024-07-17 | ABBV | GONZALEZ RICHARD A | EXECUTIVE COB OF BOARD, Dir | S - Sale+OE | $175.00 | -282.8K | 513.1K | -36% | -$49.50M |
| DMT | 2024-07-19 | 2024-07-17 | ABBV | GONZALEZ RICHARD A | EXECUTIVE COB OF BOARD, Dir | M - OptEx | $0.00 | -282.8K | 59.7K | -83% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2024-07-17 | M | A | 119,418 | $79.02 | 719,567 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value | 2024-07-17 | M | A | 76,377 | $93.50 | 795,944 | D | — | — | |
| 3 | Common | Common Stock, $0.01 par value | 2024-07-17 | M | A | 87,050 | $61.36 | 600,149 | D | — | — | |
| 4 | Common | Common Stock, $0.01 par value | 2024-07-17 | S | D | 282,845 | $175.00 | 513,099 | D | — | — | |
| 5 | Derivative | Option (Right To Buy) | 2024-07-17 | M | D | 76,377 | $0.00 | 152,755 | D | $93.50 · 2021-02-20 to 2030-02-19 | 76,377 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
| 6 | Derivative | Option (Right To Buy) | 2024-07-17 | M | D | 87,050 | $0.00 | 0 | D | $61.36 · 2018-02-16 to 2027-02-15 | 87,050 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |
| 7 | Derivative | Option (Right To Buy) | 2024-07-17 | M | D | 119,418 | $0.00 | 59,709 | D | $79.02 · 2020-02-21 to 2029-02-20 | 119,418 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |